Abstract

BackgroundEmerging evidence has revealed that some long intergenic non-coding RNAs (lincRNAs) are likely to form clusters on the same chromosome, and lincRNA genomic clusters might play critical roles in the pathophysiological mechanism. However, the comprehensive investigation of lincRNA clustering is rarely studied, particularly the characterization of their functional significance across different cancer types.MethodsIn this study, we firstly constructed a computational method basing a sliding window approach for systematically identifying lincRNA genomic clusters. We then dissected these lincRNA genomic clusters to identify common characteristics in cooperative expression, conservation among divergent species, targeted miRNAs, and CNV frequency. Next, we performed comprehensive analyses in differentially-expressed patterns and overall survival outcomes for patients from The Cancer Genome Atlas (TCGA) and The Genotype-Tissue Expression (GTEx) across multiple cancer types. Finally, we explored the underlying mechanisms of lincRNA genomic clusters by functional enrichment analysis, pathway analysis, and drug-target interaction.ResultsWe identified lincRNA genomic clusters according to the algorithm. Clustering lincRNAs tended to be co-expressed, highly conserved, targeted by more miRNAs, and with similar deletion and duplication frequency, suggesting that lincRNA genomic clusters may exert their effects by acting in combination. We further systematically explored conserved and cancer-specific lincRNA genomic clusters, indicating they were involved in some important mechanisms of disease occurrence through diverse approaches. Furthermore, lincRNA genomic clusters can serve as biomarkers with potential clinical significance and involve in specific pathological processes in the development of cancer. Moreover, a lincRNA genomic cluster named Cluster127 in DLK1-DIO3 imprinted locus was discovered, which contained MEG3, MEG8, MEG9, MIR381HG, LINC02285, AL132709.5, and AL132709.1. Further analysis indicated that Cluster127 may have the potential for predicting prognosis in cancer and could play their roles by participating in the regulation of PI3K-AKT signaling pathway.ConclusionsClarification of the lincRNA genomic clusters specific roles in human cancers could be beneficial for understanding the molecular pathogenesis of different cancer types.

Highlights

  • Long intergenic non-coding RNAs are defined as RNA transcripts longer than 200 nucleotides that do not overlap with the exons of any protein-coding gene [1]

  • We presented an algorithm for the discovery of lincRNA genomic clusters from the genomic location datasets by a sliding window approach

  • We proposed a computational algorithm basing a sliding window approach to determine whether lincRNAs are clustered on the chromosome

Read more

Summary

Introduction

Long intergenic non-coding RNAs (lincRNAs) are defined as RNA transcripts longer than 200 nucleotides that do not overlap with the exons of any protein-coding gene [1]. Acting mechanisms of lincRNAs are complex such as chromatin remodeling, co-transcriptional regulation, scaffolding of nuclear or cytoplasmic complexes, and interacting with other cellular factors [1]. Recent studies have revealed lincRNA can be potential therapeutic targets or prognostic biomarkers for various types of cancer [4]. Emerging evidence has revealed that some long intergenic non-coding RNAs (lincRNAs) are likely to form clusters on the same chromosome, and lincRNA genomic clusters might play critical roles in the pathophysiological mechanism. The comprehensive investigation of lincRNA clustering is rarely studied, the characterization of their functional significance across different cancer types

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call